Human reproduction

Personalized Letter Improves Pregnancy Weight for Women with Gestational Diabetes

Retrieved on: 
Mercoledì, Aprile 18, 2018
RTT, Women's health, Health, Obstetrics, Diabetes, Human reproduction, Maternal health, Midwifery, Gestational diabetes, Pregnancy, American Diabetes Association, Gestational age

OAKLAND, Calif., April 18, 2018 /PRNewswire/ --Women with gestational diabetes who received a tailored letter with personalized weight gain recommendations were significantly more likely to meet national weight gain guidelines, according to a new Kaiser Permanente study published today in Diabetes Care, a journal of the American Diabetes Association.

Key Points: 
  • OAKLAND, Calif., April 18, 2018 /PRNewswire/ --Women with gestational diabetes who received a tailored letter with personalized weight gain recommendations were significantly more likely to meet national weight gain guidelines, according to a new Kaiser Permanente study published today in Diabetes Care, a journal of the American Diabetes Association.
  • Gestational diabetes, the most common pregnancy complication, puts women at high risk for developing type 2 diabetes later in life; this risk is heightened for women who gain too much weight during pregnancy.
  • The study, "A Tailored Letter Based on Electronic Health Record Data Improves Gestational Weight Gain Among Women with Gestational Diabetes: The Gestational Diabetes' Effects on Moms (GEM) Cluster-Randomized Controlled Trial," involved more than 2,000 pregnant women receiving care at Kaiser Permanente facilities in Northern California.
  • Researchers aimed to identify health-system-based approaches to helping women with gestational diabetes manage weight during a critical stage of their lives.

Texas Fertility Center and Ovation Fertility™ Sponsor RESOLVE Advocacy Day Grant

Retrieved on: 
Mercoledì, Aprile 4, 2018
Fertility medicine, Human reproduction, Medicine, Health, Fertility, Infertility, Reproductive endocrinology and infertility

Texas Fertility Center and Ovation Fertility™ are sponsoring a grant, which will allow one TFC/Ovation patient and a guest to attend RESOLVE Advocacy Day 2018. The event provides an opportunity to speak to members of Congress about important fertility issues.

Key Points: 
  • Texas Fertility Center (TFC) and Ovation Fertility have announced that they are co-sponsoring a grant of up to $1500 for a TFC/Ovation patient to attend RESOLVE Advocacy Day 2018.
  • Every member of Texas Fertility Center shares a commitment to providing exceptional fertility care that is as accessible as possible to every person suffering from infertility, Dr. Silverberg says.
  • Not everyone has the resources or skills to attend Advocacy Day, so Texas Fertility Center and Ovation Fertility have teamed up to help one interested person attend this special event and make his or her voice heard on Capitol Hill, Dr. Silverberg said.
  • About Texas Fertility Center

    Texas Fertility Center (TFC), one of the nations leading full-service infertility practices, provides advanced infertility and reproductive endocrinology services to patients throughout Texas, the southwestern United States and the Americas.